Right heart catheterisation: Best practice and pitfalls in pulmonary hypertension

European Respiratory Review

Volumn 24, Issue 138, 2015, Pages 642-652

  Rosenkranz, Stephan ^a   Preston, Ioana R ^b  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIAL OXYGEN SATURATION; BALLOON CATHETER; CLINICAL EVALUATION; CLINICAL PRACTICE; COMPARATIVE STUDY; DIAGNOSTIC ERROR; FAINTNESS; HEALTH HAZARD; HEART ARRHYTHMIA; HEART CATHETERIZATION; HEART EJECTION FRACTION; HEART FAILURE; HEART OUTPUT; HEMATOMA; HEMODYNAMICS; HUMAN; HYPOTENSION; LUNG HEMORRHAGE; LUNG VASCULAR RESISTANCE; LUNG WEDGE PRESSURE; NON INVASIVE PROCEDURE; PNEUMOTHORAX; PRACTICE GUIDELINE; PRESSURE TRANSDUCER; PROGNOSIS; PULMONARY HYPERTENSION; REVIEW; RIGHT HEART CATHETERIZATION; SHUN ASSESSMENT; STANDARDIZATION; TREATMENT CONTRAINDICATION; TREATMENT RESPONSE; VASOREACTIVITY TESTING; ZEROING; ADVERSE EFFECTS; ARTERIAL PRESSURE; BENCHMARKING; DEVICES; EQUIPMENT DESIGN; HEART CATHETER; HYPERTENSION, PULMONARY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PREVENTION AND CONTROL; PULMONARY ARTERY; PULMONARY ARTERY CATHETERIZATION; REPRODUCIBILITY; STANDARDS;

ARTERIAL PRESSURE; BENCHMARKING; CARDIAC CATHETERS; CATHETERIZATION, SWAN-GANZ; DIAGNOSTIC ERRORS; EQUIPMENT DESIGN; HUMANS; HYPERTENSION, PULMONARY; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PULMONARY ARTERY; PULMONARY WEDGE PRESSURE; REPRODUCIBILITY OF RESULTS; TRANSDUCERS, PRESSURE;

EID: 84951016758     PISSN: 09059180     EISSN: 16000617     Source Type: Journal    
DOI: 10.1183/16000617.0062-2015     Document Type: Review

References (54)

1. Chatterjee K. The Swan-Ganz catheters: past, present, and future. A viewpoint. Circulation 2009; 119: 147–152.
2. Nossaman BD, Scruggs BA, Nossaman VE, et al. History of right heart catheterization: 100 years of experimentation and methodology development. Cardiol Rev 2010; 18: 94–101.
3. Hoeper MM, Bogaard HJ, Condliffe R, et al. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol 2013; 62: Suppl., D42–D50.
4. Galiè N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2015; 46: 903–975.
5. Simonneau G, Gatzoulis MA, Adatia I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013; 62: Suppl., D34–D41.
6. Saggar R, Sitbon O. Hemodynamics in pulmonary arterial hypertension: current and future perspectives. Am J Cardiol 2012; 110: Suppl., 9S–15S.
7. Deano RC, Glassner-Kolmin C, Rubenfire M, et al. Referral of patients with pulmonary hypertension diagnoses to tertiary pulmonary hypertension centers: the multicenter RePHerral study. JAMA Intern Med 2013; 173: 887–893.
8. Zuckerman WA, Turner ME, Kerstein J, et al. Safety of cardiac catheterization at a center specializing in the care of patients with pulmonary arterial hypertension. Pulm Circ 2013; 3: 831–839.
9. Rosenkranz S, Behr J, Ewert R, et al. Rechtsherzkatheter-Untersuchung bei pulmonaler Hypertonie [Right heart catheterization in pulmonary hypertension]. Dtsch Med Wochenschr 2011; 136: 2601–2616.
10. Grünig E, Peacock AJ. Imaging the heart in pulmonary hypertension: an update. Eur Respir Rev 2015; 24: 653–664.
11. Oudiz R, Langleben D. Cardiac catheterization in pulmonary arterial hypertension: an updated guide to proper use. Adv Pulm Hypertens J 2005; 4: 15–25.
12. Tsang T. Principles of echocardiography. In: Murphy JG, Lloyd MA, eds. Mayo Clinic Cardiology: Concise Textbook. 3rd Edn. Boca Raton, Mayo Clinic Scientific Press, 2008; pp. 117–142.
13. Howard C, Safdar Z. Pulmonary artery diastolic pressure gradient is an indicator of severity of illness in patients with pulmonary hypertension related to left-sided heart disease. Am J Respir Crit Care Med 2014; 189: A3865.
14. Mathier M. The nuts and bolts of interpreting hemodynamics in pulmonary hypertension associated with diastolic heart failure. Adv Pulm Hypertens J 2011; 10: 33–40.
15. Grossman W. Blood flow measurement: cardiac output and vascular resistance. In: Baim DS, ed. Grossman’s Cardiac Catheterization, Angiography, and Intervention. 7th Edn. Philadelphia, Lippincott Williams & Wilkins, 2006; pp. 148–161.
16. Abtathian F, Jang I-K. Cardiac catheterization, coronary arteriography, and intravascular diagnostics. In: Gaggin HK, Januzzi JL, eds. MGH Cardiology Board Review. London, UK, Springer-Verlag, 2014; pp. 153–173.
17. Chatterjee NA, Lewis GD. Characterization of pulmonary hypertension in heart failure using the diastolic pressure gradient: limitations of a solitary measurement. JACC Heart Fail 2015; 3: 17–21.
18. Kovacs G, Berghold A, Scheidl S, et al. Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. Eur Respir J 2009; 34: 888–894.
19. Kovacs G, Olschewski A, Berghold A, et al. Pulmonary vascular resistances during exercise in normal subjects: a systematic review. Eur Respir J 2012; 39: 319–328.
20. Kovacs G, Avian A, Pienn M, et al. Reading pulmonary vascular pressure tracings. How to handle the problems of zero leveling and respiratory swings. Am J Respir Crit Care Med 2014; 190: 252–257.
21. Lavdaniti M. Invasive and non-invasive methods for cardiac output measurement. Int J Caring Sciences 2008; 1: 112–117.
22. Miller A, Soukoulis V, Lilly LS. Section I. Fundamentals of cardiovascular disease; genetics and personalized medicine; evaluation of the patient. In: Lilly LS, ed. Braunwald’s Heart Disease. Review and Assessment. 9th Edn. Philadelphia, Elsevier Saunders, 2012; pp. 1–86.
23. Wensel R, Francis DP, Meyer FJ, et al. Incremental prognostic value of cardiopulmonary exercise testing and resting haemodynamics in pulmonary arterial hypertension. Int J Cardiol 2013; 167: 1193–1198.
24. Rich S, Kaufmann E, Levy PS. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med 1992; 327: 76–81.
25. Sitbon O, Humbert M, Jais X, et al. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation 2005; 111: 3105–3111.
26. Montani D, Savale L, Natali D, et al. Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension. Eur Heart J 2010; 31: 1898–1907.
27. Oliveira EC, Amaral CF, Moura MA, et al. Testing pulmonary vasoreactivity. J Bras Pneumol 2008; 34: 838–844.
28. Farber HW, Gibbs S. Under pressure: pulmonary hypertension associated with left heart disease. Eur Respir Rev 2015; 24: 665–673.
29. Tonelli AR, Mubarak KK, Li N, et al. Effect of balloon inflation volume on pulmonary artery occlusion pressure in patients with and without pulmonary hypertension. Chest 2011; 139: 115–121.
30. LeVarge BL, Pomerantsev E, Channick RN. Reliance on end-expiratory wedge pressure leads to misclassification of pulmonary hypertension. Eur Respir J 2014; 44: 425–434.
31. Ryan JJ, Rich JD, Thiruvoipati T, et al. Current practice for determining pulmonary capillary wedge pressure predisposes to serious errors in the classification of patients with pulmonary hypertension. Am Heart J 2012; 163: 589–594.
32. Hansdottir S, Groskreutz DJ, Gehlbach BK. WHO’s in second?: A practical review of World Health Organization group 2 pulmonary hypertension. Chest 2013; 144: 638–650.
33. Narang N, Thibodeau JT, Levine BD, et al. Inaccuracy of estimated resting oxygen uptake in the clinical setting. Circulation 2014; 129: 203–210.
34. Hoeper MM, Lee SH, Voswinckel R, et al. Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. J Am Coll Cardiol 2006; 48: 2546–2552.
35. Ranu H, Smith K, Nimako K, et al. A retrospective review to evaluate the safety of right heart catheterization via the internal jugular vein in the assessment of pulmonary hypertension. Clin Cardiol 2010; 33: 303–306.
36. Gupta D, Karrowni W, Chatterjee K. Swan-Ganz catheters. In: Chatterjee K, Anderson M, Heistad D, et al., eds. Cardiology: An Illustrated Textbook. New Delhi, Jaypee Brothers Medical Publishers Ltd, 2012; pp. 503–516.
37. Martin UJ, Krachman S. Hemodynamic monitoring. In: Criner GJ, D’Alonzo GE, eds. Critical Care Study Guide: Text and Review. Philadelphia, Springer-Verlag, 2002; pp. 44–69.
38. Kern MJ, Sorajja P, Lim M. The Cardiac Catheterization Handbook. 6th Edn. Oxford, Elsevier Health Sciences, 2015.
39. Robbins IM, Hemnes AR, Pugh ME, et al. High prevalence of occult pulmonary venous hypertension revealed by fluid challenge in pulmonary hypertension. Circ Heart Fail 2014; 7: 116–122.
40. Fujimoto N, Borlaug BA, Lewis GD, et al. Hemodynamic responses to rapid saline loading: the impact of age, sex, and heart failure. Circulation 2013; 127: 55–62.
41. Frost AE, Farber HW, Barst RJ, et al. Demographics and outcomes of patients diagnosed with pulmonary hypertension with pulmonary capillary wedge pressures 16 to 18 mm Hg: insights from the REVEAL Registry. Chest 2013; 143: 185–195.
42. Borlaug BA, Nishimura RA, Sorajja P, et al. Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ Heart Fail 2010; 3: 588–595.
43. Boerrigter BG, Waxman AB, Westerhof N, et al. Measuring central pulmonary pressures during exercise in COPD: how to cope with respiratory effects. Eur Respir J 2014; 43: 1316–1325.
44. McLaughlin VV, Langer A, Tan M, et al. Contemporary trends in the diagnosis and management of pulmonary arterial hypertension: an initiative to close the care gap. Chest 2013; 143: 324–332.
45. Coghlan JG, Denton CP, Grunig E, et al. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study. Ann Rheum Dis 2014; 73: 1340–1349.
46. Bossone E, Dellegrottaglie S, Patel S, et al. Multimodality imaging in pulmonary hypertension. Can J Cardiol 2015; 31: 440–459.
47. Constantinescu T, Magda SL, Niculescu R, et al. New echocardiographic tehniques in pulmonary arterial hypertension vs. right heart catheterization – a pilot study. Maedica (Buchar) 2013; 8: 116–123.
48. Fisher MR, Forfia PR, Chamera E, et al. Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med 2009; 179: 615–621.
49. El-Korashy RIM, Amin YM, Eissa AI, et al. Echocardiography versus right heart catheterization in class I pulmonary hypertension. Egypt J Chest Dis Tuberc 2014; 63: 419–422.
50. Humbert M, Sitbon O, Yaici A, et al. Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension. Eur Respir J 2010; 36: 549–555.
51. Nickel N, Golpon H, Greer M, et al. The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension. Eur Respir J 2012; 39: 589–596.
52. Benza RL, Miller DP, Gomberg-Maitland M, et al. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation 2010; 122: 164–172.
53. Mukerjee D, St George D, Coleiro B, et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 2003; 62: 1088–1093.
54. Chaouat A, Sitbon O, Mercy M, et al. Prognostic value of exercise pulmonary haemodynamics in pulmonary arterial hypertension. Eur Respir J 2014; 44: 704–713.